Extension of Time to File SOU

HERCEPTIN HYLECTA

Genentech, Inc.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88232272
LAW OFFICE ASSIGNED LAW OFFICE 109
MARK SECTION
MARK HERCEPTIN HYLECTA (see, http://uspto.report/TM/88232272/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT HERCEPTIN HYLECTA
OWNER SECTION (current)
NAME Genentech, Inc.
MAILING ADDRESS 1 DNA Way
CITY South San Francisco
STATE California
ZIP/POSTAL CODE 94080
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 650-467-1936
FAX 6509529881
EMAIL XXXX
OWNER SECTION (proposed)
NAME Genentech, Inc.
MAILING ADDRESS 1 DNA Way
CITY South San Francisco
STATE California
ZIP/POSTAL CODE 94080
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 650-467-1936
FAX 6509529881
EMAIL XXXX
ATTORNEY INFORMATION (current)
NAME Shameek Ghose
ATTORNEY BAR MEMBERSHIP NUMBER NOT SPECIFIED
YEAR OF ADMISSION NOT SPECIFIED
U.S. STATE/ COMMONWEALTH/ TERRITORY NOT SPECIFIED
STREET 1 DNA WAY
CITY SOUTH SAN FRANCISCO
STATE California
POSTAL CODE 94080
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 650-467-1936
EMAIL docketing-d@gene.com
DOCKET/REFERENCE NUMBER TM-40325-US
ATTORNEY INFORMATION (proposed)
NAME Shameek Ghose
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
STREET 1 DNA WAY
CITY SOUTH SAN FRANCISCO
STATE California
POSTAL CODE 94080
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 650-467-1936
FAX 6509529881
EMAIL ghoses@gene.com
DOCKET/REFERENCE NUMBER TM-40325-US
CORRESPONDENCE INFORMATION (current)
NAME SHAMEEK GHOSE
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing-d@gene.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
CORRESPONDENCE INFORMATION (proposed)
NAME Shameek Ghose
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ghoses@gene.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) docketing-d@gene.com; trademarks-d@gene.com
DOCKET/REFERENCE NUMBER TM-40325-US
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations for the treatment of cancer
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 12/10/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Shameek Ghose/
SIGNATORY'S NAME Shameek Ghose
SIGNATORY'S POSITION Sr. IP Counsel/Head of Pharma Trademarks & Authorized Corporate Signatory
DATE SIGNED 05/18/2020
SIGNATORY'S PHONE NUMBER 6504671936
FILING INFORMATION
SUBMIT DATE Mon May 18 12:40:00 ET 2020
TEAS STAMP USPTO/ESU-XX.XX.XXX.XXX-2
0200518124000406374-88232
272-71099ccb3e1f3a63697d6
c4609d9042c4e28232add4426
b5285496bc4df3c3efab-DA-3
9591183-20200518123616001
355



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: HERCEPTIN HYLECTA (see, http://uspto.report/TM/88232272/mark.png)
SERIAL NUMBER: 88232272

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Genentech, Inc., having an address of
      1 DNA Way
      South San Francisco, California 94080
      United States
      Phone: 650-467-1936
      Fax: 6509529881
      Email: XXXX
Proposed: Genentech, Inc., having an address of
      1 DNA Way
      South San Francisco, California 94080
      United States
      Phone: 650-467-1936
      Fax: 6509529881
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 12/10/2019.

For International Class 005:
Current identification: Pharmaceutical preparations for the treatment of cancer

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

The applicant's current Attorney Information:
      Shameek Ghose
      1 DNA WAY
      SOUTH SAN FRANCISCO, California 94080
      United States
      Phone: 650-467-1936
      The docket/reference number is TM-40325-US
      Email: docketing-d@gene.com


The applicant's proposed Attorney Information:
      Shameek Ghose
      1 DNA WAY
      SOUTH SAN FRANCISCO, California 94080
      United States
      Phone: 650-467-1936
      Fax: 6509529881
      The docket/reference number is TM-40325-US
      Email: ghoses@gene.com


Correspondence Information (current):
      SHAMEEK GHOSE
      PRIMARY EMAIL FOR CORRESPONDENCE: docketing-d@gene.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

Correspondence Information (proposed):
      Shameek Ghose
      PRIMARY EMAIL FOR CORRESPONDENCE: ghoses@gene.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): docketing-d@gene.com; trademarks-d@gene.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Shameek Ghose/      Date Signed: 05/18/2020
Signatory's Name: Shameek Ghose
Signatory's Position: Sr. IP Counsel/Head of Pharma Trademarks & Authorized Corporate Signatory
Signatory's Phone: 6504671936

Mailing Address:
   
   
   1 DNA WAY
   SOUTH SAN FRANCISCO, California 94080

RAM Sale Number: 88232272
RAM Accounting Date: 05/18/2020

Serial Number: 88232272
Internet Transmission Date: Mon May 18 12:40:00 ET 2020
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XXX-2020051812400040
6374-88232272-71099ccb3e1f3a63697d6c4609
d9042c4e28232add4426b5285496bc4df3c3efab
-DA-39591183-20200518123616001355




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed